Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials

View Full Paper

Ask AI

Bookmark

No abstract yet

We only have this paper's title and publication details.

https://www.crd.york.ac.uk/prospero, identifier (CRD42023437126).

No takes yet. Share an insight, caveat, or question.

Liang et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark